An attempt to inhibit the course of amyotrophic lateral sclerosis (ALS) by suppressor factor

Biotherapy

Volumn 9, Issue 1-3, 1996, Pages 139-141

  Nevsimal, Oldrich ^a   Pekarek, Jan ^b   Cech, Karel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b SEVAC   (Czech Republic)

Author keywords

amyotrophic lateral sclerosis; autoimmunity; CD8 lymphocytes; suppressor factor; transfer factor

Indexed keywords

CD8 ANTIGEN; IMMUNE TRANSFER FACTOR; SUPPRESSOR FACTOR; TRANSFER FACTOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AUTOIMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DEATH; DISEASE COURSE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; LIFESPAN; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

EID: 0029729574     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02628671     Document Type: Conference Paper

References (6)

1. Borkowsky W, Berger J, Pison R & Lawrence R. Antigen specific suppressor factor in human leukocyte dialysates. Immunology of Transfer Factor, New York: Academic Press, 1983:91.
2. Pekarek J, Cech J, Nevsimal O, et al. The use of OLE - TF fraction with the suppressive effect in some autoaggressive diseases. Recent Adv. in Transfer Factor and Dialyzable leucocyte Extracts. Tokyo, 1990: 326.
3. Stancikova M, Rovensky J, Pekarek J, et al. Influence of various forms of dialyzable leukocyte extracts on rat adjuvant arthritis. Arch Immunol Therap Exp 1994; 42: 295-99.
4. Cervenkova D, Keleova A, Jahnova E, et al. Therapy of atopic dermatitis with suppressor factor. Klin Imunol Allergol 1994; 3:37.
5. Nevsimal O, Pekarek J, Svejcar J & Suessova J. Delayed type hypersensitivity to polio viruses in patients with ALS. Cs Neurol Neurochir 1985; 288:48-81.
6. Nevsimal O, Kalous J, Pekarek J & Cech K. Decline of ALS symptoms during the therapy with low molecular weight suppressor factor. Ceska a Slovenska Neurol. Neurochir. 1994; 60: 57-90.